Mountain flora in the Kaokoveld deserve priority conservation efforts.
Academic rigor, journalistic flair
Articles on Endemic
Displaying all articles
The current increase in infections is not any surprise to disease scientists – nor is it anything to be too concerned about.
With the emergency phase of the COVID-19 pandemic in the rearview mirror, at least for now, we look back on a handful of stories that provided sharp insights at key moments in the pandemic.
As COVID-19 transitions from a pandemic to an endemic, apocalyptic science-fiction and zombie movies contain examples of how to adjust to the new normal.
A new generation of vaccines and boosters against SARS-CoV-2 may take a page from the anti-influenza playbook, with shots periodically tailored to target the most commonly circulating virus strains.
Repeated resurgences of SARS-CoV-2 transmission are expected in the years to come.
Endemic doesn’t mean we drop our guard, surrender to the virus or downgrade the threat the virus poses to individuals and the community.
None of our authors can see the future, but many do have expertise that offers insights about what’s reasonable to expect.
If COVID symptoms are less severe, people with the Omicron variant may be less likely to test and isolate.
At the beginning of 2020, most people hadn’t used the word ‘pandemic’ before. Now it’s time to understand the term ‘endemic’ and find out what to expect when COVID changes shape.
As ready as you are to be done with COVID-19, it’s not going anywhere soon. A historian of disease describes how once a pathogen emerges, it’s usually here to stay.
It brought panic, fear and huge pressure on healthcare. Will we get it wrong again?
An economics risk analysis offers some insight into the modern anti-vaxx movement.
Top contributors
-
Associate Professor of History, Rutgers University - Newark
-
Assistant Professor of History, University of Pittsburgh
-
Pediatric Infectious Diseases Fellow, University of Pittsburgh
-
Director: SACEMA, South African Centre for Epidemiological Modelling & Analysis (SACEMA)
-
Assistant Professor of Epidemiology, Texas A&M University
-
Emeritus Professor of Medicine and Honorary Senior Research Fellow in English, University of Bristol
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Assistant Director of the Center for the History of Medicine, University of Michigan
-
Chair in Epidemiology, Deakin University
-
Research Leader in Virology and Infectious Disease, Griffith University
-
Microbiologist, Griffith University
-
Adjunct Professor of Epidemiology, University of Texas Health Science Center at Houston
-
Principal Researcher - Epidemiology, Wits-VIDA, University of the Witwatersrand
-
Professor of Molecular, Cellular and Developmental Biology, University of Colorado Boulder
